What Is the Most Effective Treatment for Nocturia or Nocturnal Incontinence in Adult Women?

European Urology Focus - Tập 7 - Trang 453-463 - 2021
Dina Bedretdinova1, David Ambühl2, Muhammad Imran Omar3, Vasileios Sakalis4, Nikesh Thiruchelvam5, Marc Schneider2, Arjun Nambiar6, Ruud Bosch7
1Inserm, CESP U1018, Villejuif, France
2Department of Urology, University Hospital Bern, Inselspital Anna Seiler-Haus, Bern, Switzerland
3European Association of Urology Guidelines Office, Arnhem, The Netherlands
4Department of Urology, General Hospital of Thessaloniki Agios Pavlos, Thessaloniki, Greece
5Department of Urology, Cambridge University Hospitals NHS Trust, Cambridge, UK
6Department of Urology, Freeman Hospital, Newcastle Upon Tyne, UK
7Department of Urology, University Medical Centre Utrecht, Utrecht, The Netherlands

Tài liệu tham khảo

Fowler, 2008, The neural control of micturition, Nat Rev Neurosci, 9, 453, 10.1038/nrn2401 Hashim, 2019, International Continence Society (ICS) report on the terminology for nocturia and nocturnal lower urinary tract function, Neurourol Urodyn, 38, 499, 10.1002/nau.23917 Bosch, 2010, The prevalence and causes of nocturia, J Urol, 184, 440, 10.1016/j.juro.2010.04.011 Burgio, 2010, Prevalence and correlates of nocturia in community-dwelling older adults, J Am Geriatr Soc, 58, 861, 10.1111/j.1532-5415.2010.02822.x Fitzgerald, 2007, The association of nocturia with cardiac disease, diabetes, body mass index, age and diuretic use: results from the BACH survey, J Urol, 177, 1385, 10.1016/j.juro.2006.11.057 Temml, 2009, Nocturia is an age-independent risk factor for hip-fractures in men, Neurourol Urodyn, 28, 949, 10.1002/nau.20712 Tikkinen, 2010, Nocturia frequency, bother, and quality of life: how often is too often? A population-based study in Finland, Eur Urol, 57, 488, 10.1016/j.eururo.2009.03.080 Weiss, 2012, Nocturia: focus on etiology and consequences, Rev Urol, 14, 48 Committee for Establishment of the Clinical Guidelines for Nocturia of the Neurogenic Bladder Society, 2010, Clinical guidelines for nocturia, Int J Urol, 17, 397, 10.1111/j.1442-2042.2010.02527.x Cornu, 2012, A contemporary assessment of nocturia: definition, epidemiology, pathophysiology, and management—a systematic review and meta-analysis, Eur Urol, 62, 877, 10.1016/j.eururo.2012.07.004 Marshall, 2015, Nocturia: current levels of evidence and recommendations from the International Consultation on Male Lower Urinary Tract Symptoms, Urology, 85, 1291, 10.1016/j.urology.2015.02.043 Weatherall, 2006, Nocturia in adults: draft New Zealand guidelines for its assessment and management in primary care, N Z Med J, 119, U1976 Sakalis, 2017, Medical treatment of nocturia in men with lower urinary tract symptoms: systematic review by the European Association of Urology Guidelines Panel for male lower urinary tract symptoms, Eur Urol, 72, 757, 10.1016/j.eururo.2017.06.010 Knoll, 2018, Key steps in conducting systematic reviews for underpinning clinical practice guidelines: methodology of the European Association of Urology, Eur Urol, 73, 290, 10.1016/j.eururo.2017.08.016 Moher, 2009, Preferred Reporting Items for Systematic Reviews and Meta-analyses: the PRISMA statement, PLoS Med, 6, 10.1371/journal.pmed.1000097 Higgins, 2011, The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials, BMJ, 343, d5928, 10.1136/bmj.d5928 Deeks, 2003, Evaluating non-randomised intervention studies, Health Technol Assess, 7, 10.3310/hta7270 Higgins, 2013, Issues relating to study design and risk of bias when including non-randomized studies in systematic reviews on the effects of interventions, Res Synth Methods, 4, 12, 10.1002/jrsm.1056 Popay, 2006, Guidance on the conduct of narrative synthesis in systematic reviews, ESRC Methods Programme Hilton, 1982, The use of desmopressin (DDAVP) in nocturnal urinary frequency in the female, Br J Urol, 54, 252, 10.1111/j.1464-410X.1982.tb06969.x Lose, 2003, Efficacy of desmopressin (Minirin) in the treatment of nocturia: a double-blind placebo-controlled study in women, Am J Obstet Gynecol, 189, 1106, 10.1067/S0002-9378(03)00593-3 Yamaguchi, 2013, Gender difference in efficacy and dose response in Japanese patients with nocturia treated with four different doses of desmopressin orally disintegrating tablet in a randomized, placebo-controlled trial, BJU Int, 111, 474, 10.1111/j.1464-410X.2012.11547.x Rovner, 2018, Low-dose desmopressin and tolterodine combination therapy for treating nocturia in women with overactive bladder: a double-blind, randomized, controlled study, Low Urin Tract Symptoms, 10, 221, 10.1111/luts.12169 Johnson, 2005, Effects of behavioral and drug therapy on nocturia in older incontinent women, J Am Geriatr Soc, 53, 846, 10.1111/j.1532-5415.2005.53260.x Fitzgerald, 2008, Nocturia, nocturnal incontinence prevalence, and response to anticholinergic and behavioral therapy, Int Urogynecol J Pelvic Floor Dysfunct, 19, 1545, 10.1007/s00192-008-0687-7 Yuan, 2011, Comparison of tolterodine with estazolam versus tolterodine alone for the treatment of women with overactive bladder syndrome and nocturia: a non-randomized prospective comparative study, Pak J Med Sci, 27 Lose, 2000, Oestradiol-releasing vaginal ring versus oestriol vaginal pessaries in the treatment of bothersome lower urinary tract symptoms, BJOG, 107, 1029, 10.1111/j.1471-0528.2000.tb10408.x Lo, 2003, Additive effect of interferential therapy over pelvic floor exercise alone in the treatment of female urinary stress and urge incontinence: a randomized controlled trial, Hong Kong Physiother J, 21, 37, 10.1016/S1013-7025(09)70038-7 But, 2005, Functional magnetic stimulation for mixed urinary incontinence, J Urol, 173, 1644, 10.1097/01.ju.0000157336.87781.32 Aslan, 2008, Bladder training and Kegel exercises for women with urinary complaints living in a rest home, Gerontology, 54, 224, 10.1159/000133565